Both in Biotechnology
Monte Rosa Therapeutics vs Solid Biosciences
Over the past year GLUE returned +7.7% and SLDB returned −4.6%; their daily moves had a correlation of 0.29.
GLUE +7.7% SLDB −4.6%Growth of $1, one year, split-adjusted
| Metric | GLUE | SLDB |
|---|---|---|
| Price | $10.63 | $5.87 |
| Market cap | $906.9M | $628.9M |
| Today | +9.14% | +6.06% |
| 1 month | −12.4% | −34.2% |
| 6 months | −46.3% | −30.9% |
| Year to date | −32.2% | +4.0% |
| 1 year | +3.1% | −4.8% |
| Revenue growth (YoY) | −61.3% | — |
| Gross margin | 100.0% | — |
| Net margin | −483.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 31.6× | — |
| Net cash | $621.1M | $377.7M |
| Dividend yield | — | — |
| Volatility (60d) | 82.8% | 65.9% |
| Short % of float | 39.9% | 18.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).